Check Cap Ltd
NASDAQ:CHEK
Intrinsic Value
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule system for colorectal cancer screening. [ Read More ]
The intrinsic value of one CHEK stock under the Base Case scenario is 4.8 USD. Compared to the current market price of 2.27 USD, Check Cap Ltd is Undervalued by 53%.
Valuation Backtest
Check Cap Ltd
Run backtest to discover the historical profit from buying and selling CHEK stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Check Cap Ltd
Current Assets | 28.8m |
Cash & Short-Term Investments | 28.1m |
Other Current Assets | 707k |
Non-Current Assets | 256k |
PP&E | 256k |
Current Liabilities | 1.6m |
Accounts Payable | 108k |
Accrued Liabilities | 787k |
Other Current Liabilities | 740k |
Earnings Waterfall
Check Cap Ltd
Revenue
|
0
USD
|
Operating Expenses
|
-18m
USD
|
Operating Income
|
-18m
USD
|
Other Expenses
|
383k
USD
|
Net Income
|
-17.6m
USD
|
Free Cash Flow Analysis
Check Cap Ltd
CHEK Profitability Score
Profitability Due Diligence
Check Cap Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
Score
Check Cap Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
CHEK Solvency Score
Solvency Due Diligence
Check Cap Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Score
Check Cap Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CHEK Price Targets Summary
Check Cap Ltd
According to Wall Street analysts, the average 1-year price target for CHEK is 7 USD .
Shareholder Return
CHEK Price
Check Cap Ltd
Average Annual Return | -46.03% |
Standard Deviation of Annual Returns | 28.36% |
Max Drawdown | -98% |
Market Capitalization | 13.3m USD |
Shares Outstanding | 5 850 000 |
Percentage of Shares Shorted | 10.27% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule system for colorectal cancer screening. The company employs 81 full-time employees The company went IPO on 2015-02-19. The firm develops C-Scan, capsule-based, system ingestible imaging for colorectal cancer screening.
Contact
IPO
Employees
Officers
The intrinsic value of one CHEK stock under the Base Case scenario is 4.8 USD.
Compared to the current market price of 2.27 USD, Check Cap Ltd is Undervalued by 53%.